Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

An observational study of olanzapine coated and orodispersible tablets effectiveness in schizophrenic and bipolar outpatients.

Next Previous
X
Search
Trial Profile

An observational study of olanzapine coated and orodispersible tablets effectiveness in schizophrenic and bipolar outpatients.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 26 Oct 2015

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Olanzapine (Primary)
  • Indications Bipolar disorders; Schizoaffective disorder; Schizophrenia
  • Focus Therapeutic Use
  • Sponsors Eli Lilly and Company

    • Most Recent Events

    • 01 Sep 2015 Results of post hoc analysis are presented at the 28th Annual Congress of the European College of Neuropsychopharmacology
    • 05 Aug 2009 Actual end date (May 2009) added as reported by ClinicalTrials.gov.
    • 05 Aug 2009 Actual patient number (1131) added as reported by ClinicalTrials.gov.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top